We are live on ! Find out more
PDLI

PDL BioPharma, Inc.
PDLI

Delisted

PDLI was delisted on the 30th of December, 2020.

Back to rankings

7 hedge funds and large institutions have $28K invested in PDL BioPharma, Inc. in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more funds holding

Funds holding: 5 → 7 (+2)

0% more capital invested

Capital invested by funds: $28K → $28K ($0)

Holders
7
Holders Change
+2
Holders Change %
+40%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

PDLI Hedge Fund Activity: Q4 2024 in Review

7 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in PDL BioPharma, Inc. (PDLI) for Q4 2024, worth a combined $28K — unchanged from a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new PDLI positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.

  • 7 institutional investors held PDL BioPharma, Inc. (PDLI) as of Q4 2024, up from 5 in Q3 2024.
  • Funds reported $28K of PDL BioPharma, Inc. stock for Q4 2024, unchanged quarter-over-quarter.
  • 2 funds opened new PDL BioPharma, Inc. positions in Q4 2024 and 0 closed out, a net change of +2 holders.

Based on aggregated 13F filings for Q4 2024.